NVST
Envista Holdings Corp. · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website envistaco.com
- Employees(FY) 12700
- ISIN US29415F1049
Performance
-4.32%
1W
-7.97%
1M
-22.32%
3M
-12.26%
6M
-21.74%
YTD
-45.92%
1Y
Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Investment Analysis Report: NVST
Overview
In this investment analysis report, we will delve into the financial statements of NVST, a company operating in the Health Technology sector with a market capitalization of $3.86 billion. We will analyze the company's Balance Sheets, Income Statements, and Cashflow Statements over the past three years to...
Technical Analysis of NVST 2024-05-03
Overview:
In analyzing the technical indicators for NVST over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide investment ...
Recent News & Updates
- 2024-05-04 08:01
- 2024-05-03 06:09
- 2024-05-02 11:04
- 2024-05-02 10:54
- 2024-05-02 03:45
- 2024-05-01 22:54
- 2024-05-01 21:16
Q1 2024 Envista Holdings Corp Earnings Call(Yahoo Finance)
- 2024-05-01 19:30
- 2024-05-01 17:36
- 2024-05-01 17:25
- 2024-05-01 16:24
Envista: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-01 16:10
Envista Reports First Quarter 2024 Results(PR Newswire)
- 2024-05-01 08:54
- 2024-05-01 05:25
- 2024-05-01 04:10
Envista Reports First Quarter 2024 Results(Prnewswire)
- 2024-04-26 06:50
- 2024-04-25 08:00
Buick, GM’s low-key semi-luxury brand, is suddenly hot(CNN Business)
- 2024-04-23 20:00
NVST: What does Argus have to say about NVST?(Argus Research)
- 2024-04-20 09:16
10 Best Healthcare Stocks to Buy Under $20(Insider Monkey)
- 2024-04-19 21:16
10 Best Healthcare Stocks to Buy Under $20(Insidermonkey)
- 2024-04-15 16:10
Envista Announces CEO Appointment(PR Newswire)
- 2024-04-15 04:10
Envista Announces CEO Appointment(Prnewswire)
- 2024-04-11 16:10
Envista Smile Project Donates $1.2 Million in 2023(PR Newswire)
- 2024-04-11 04:10
- 2024-04-04 16:10
Envista Schedules First Quarter 2024 Earnings Call(PR Newswire)
- 2024-04-04 04:10
- 2024-03-29 03:14
- 2024-03-28 15:14
- 2024-03-20 06:07
Return Trends At Envista Holdings (NYSE:NVST) Aren't Appealing(Simply Wall St.)
- 2024-03-19 11:35
Page 1 of 6
previousnext